Humanized anti-CD117 Monoclonal Antibody (JSP191)
JSP-CP-003
Phase 1 mab active
Quick answer
Humanized anti-CD117 Monoclonal Antibody (JSP191) for MYELODYSPLASTIC SYNDROME; MDS is a Phase 1 program (mab) at Jasper Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jasper Therapeutics
- Indication
- MYELODYSPLASTIC SYNDROME; MDS
- Phase
- Phase 1
- Modality
- mab
- Status
- active